NADAL® TPHA Microplate Hemagglutination Test - 100 Tests

The NADAL® TPHA microplate hemagglutination test is an advanced diagnostic solution for the detection of antibodies against Treponema pallidum, the pathogenic agent responsible for syphilis. This test is designed to provide rapid and reliable results, making it an essential tool for healthcare professionals in the diagnosis and management of this venereal disease.

Product Description

The NADAL® TPHA test uses an indirect hemagglutination methodology, which makes it possible to qualitatively and semiquantitatively identify the presence of specific antibodies in human serum. Thanks to the use of stabilized avian erythrocytes sensitized with T. pallidum antigens, the test produces a visually recognizable agglutination pattern in the presence of antibodies, thus facilitating result interpretation.

Test Strengths

• Reliability: Uses a proven technology to ensure accurate results.


• Speed: Results can be read immediately after performing the test.


• Ease of use: Designed for simple and straightforward use in the laboratory.

Clinical Indications

Syphilis is a venereal disease transmitted through direct contact with active syphilitic lesions. With an incubation period of about 20 days, syphilis manifests in three stages, each with varying symptoms. It is important to note that specific antibodies against T. pallidum can persist in 85-90% of patients even after treatment and recovery, making this test essential for early diagnosis and disease monitoring.

Package Contents

Each package contains:

• 100 Microplate Hemagglutination Tests


• Packaging designed to ensure integrity and reliability

Technical Specifications

• Test Format: Diagglutination test


• Test Evaluation: Qualitative and semiquantitative results


• Sample Type: Serum


• Detected Parameter: IgM and IgG antibodies against Treponema pallidum


• Detection Time: Results available immediately after performing the test


• Storage Temperature: Store between 2 and 8 °C


• Certifications: CE marked

Use

This test is designed exclusively for in vitro diagnostic use by healthcare professionals, mainly in clinical and hospital laboratories. The NADAL® TPHA microplate hemagglutination test represents a rapid and reliable diagnostic option, essential for the early diagnosis and management of syphilis. Thanks to its ease of use and rapid results, it contributes to effective and timely control of the infection, thereby improving public health.